Fund shareholders of Nektar Therapeutics
ISIN US6402683063 · United States · LEI 5299005I24806IOIYE03
- Fund shareholders
- 83
- Of which ETFs
- 19 64 other funds
- Value held
- 384.3M $
- Share of capital
- 15.4 % of 34.1M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,155,001 | 79.7M $ | 0.10 % | 3.38 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 855,600 | 61.6M $ | 0.00 % | 2.51 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 312,805 | 22.5M $ | 0.03 % | 0.92 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 308,614 | 21.3M $ | 0.10 % | 0.90 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 279,460 | 19.3M $ | 0.08 % | 0.82 % | as of Feb 28, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 273,886 | 23.3M $ | 1.05 % | 0.80 % | as of Apr 30, 2026 ↗ |
| Invesco Main Street Small Cap Fund AIM Growth Series (Invesco Growth Series) | 181,904 | 13.1M $ | 0.59 % | 0.53 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 178,419 | 15.2M $ | 0.22 % | 0.52 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 140,820 | 9.7M $ | 0.02 % | 0.41 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 130,800 | 9M $ | 0.04 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 104,721 | 8.9M $ | 0.63 % | 0.31 % | as of Apr 30, 2026 ↗ |
| Invesco V.I. Main Street Small Cap Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 96,504 | 6.9M $ | 0.59 % | 0.28 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 90,281 | 7.7M $ | 0.33 % | 0.26 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Core Fund DEUTSCHE DWS INVESTMENT TRUST | 90,000 | 6.5M $ | 0.62 % | 0.26 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 80,506 | 5.8M $ | 1.88 % | 0.24 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 78,204 | 5.6M $ | 0.56 % | 0.23 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 72,788 | 5M $ | 0.02 % | 0.21 % | as of Feb 28, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 67,915 | 5.8M $ | 0.11 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 63,081 | 5.4M $ | 0.19 % | 0.18 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 50,350 | 3.5M $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 50,114 | 3.5M $ | 3.61 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 42,431 | 3.6M $ | 1.77 % | 0.12 % | as of Apr 30, 2026 ↗ |
| MassMutual Small Cap Opportunities Fund MASSMUTUAL PREMIER FUNDS | 42,037 | 3M $ | 0.59 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 39,667 | 2.7M $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 38,090 | 2.7M $ | 0.00 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 36,570 | 3.1M $ | 2.57 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 34,239 | 2.9M $ | 0.14 % | 0.10 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 20,950 | 1.8M $ | 0.19 % | 0.06 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 20,366 | 1.5M $ | 0.84 % | 0.06 % | as of Mar 31, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 19,035 | 1.6M $ | 2.66 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 18,563 | 1.6M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 17,092 | 1.2M $ | 0.18 % | 0.05 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 16,955 | 1.2M $ | 0.03 % | 0.05 % | as of Feb 27, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 15,648 | 1.1M $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 15,256 | 1.1M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 14,419 | 1.2M $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 12,911 | 928.9K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,772 | 812K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 11,598 | 986.3K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 11,131 | 946.6K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Special Situations ETF RBB Fund, Inc. | 10,455 | 889.1K $ | 3.11 % | 0.03 % | as of Apr 30, 2026 ↗ |
| MML VIP Invesco Small Cap Equity Fund MML Series Investment Fund II | 10,221 | 735.4K $ | 0.59 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 9,853 | 837.9K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| ALGER CAPITAL APPRECIATION FUND ALGER FUNDS | 9,435 | 802.4K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Inception Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 8,982 | 646.3K $ | 0.27 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Empower Small Cap Growth Fund EMPOWER FUNDS, INC. | 8,646 | 622.1K $ | 0.27 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Alger Dynamic Opportunities Fund ALGER FUNDS II | 8,583 | 729.9K $ | 0.33 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 6,613 | 456.2K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 6,377 | 458.8K $ | 0.12 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 5,930 | 409.1K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 5,655 | 406.9K $ | 0.70 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 5,045 | 429K $ | 1.15 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 4,961 | 356.9K $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,660 | 335.3K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 4,219 | 358.8K $ | 0.09 % | 0.01 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 4,000 | 287.8K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Growth ETF iShares Trust | 3,496 | 297.3K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,127 | 265.9K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 3,038 | 258.4K $ | 3.17 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Morningstar Small-Cap Value ETF iShares Trust | 2,748 | 233.7K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 2,554 | 183.8K $ | 1.81 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 2,353 | 200.1K $ | 1.55 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Allspring Disciplined Small Cap Fund ALLSPRING FUNDS TRUST | 1,870 | 134.5K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 1,412 | 101.6K $ | 4.75 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 1,382 | 99.4K $ | 0.46 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 1,362 | 98K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PACE Small/Medium Co Growth Equity Investments PACE SELECT ADVISORS TRUST | 1,318 | 112.1K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,300 | 89.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 1,060 | 90.1K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 770 | 65.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 605 | 51.4K $ | 1.53 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 485 | 34.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 324 | 23.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 308 | 22.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Next Index ETF RBB Fund, Inc. | 301 | 20.8K $ | 0.06 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 160 | 11.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 127 | 9.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 107 | 9.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 102 | 8.7K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 60 | 5.1K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 21 | 1.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 1 | 72 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 1 | 72 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 4.75 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 3.61 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 3.17 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Special Situations ETF RBB Fund, Inc. | 3.11 % | as of Apr 30, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 2.66 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 2.57 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.88 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.81 % | as of Mar 31, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 1.77 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.55 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 83 | +14 | 5,244,530 | +105.0 % |
| 2026Q1 | 69 | +8 | 2,558,658 | +20.1 % |
| 2025Q4 | 61 | -2 | 2,131,256 | +37.1 % |
| 2025Q3 | 63 | 1,554,732 |
Institutional managers
198 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 4,303,188 | 309.6M $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,559,595 | 184.2M $ | as of Mar 31, 2026 |
| Two Seas Capital LP | 1,959,178 | 141M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 930,741 | 67M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 735,000 | 52.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 692,650 | 49.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 659,387 | 47.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 578,000 | 41.6M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 567,458 | 40.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 513,531 | 36.9M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 509,546 | 36.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 415,335 | 29.9M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 405,080 | 29.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 404,277 | 29.1M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 394,604 | 28.4M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 390,675 | 28.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 346,795 | 25M $ | as of Mar 31, 2026 |
| UBS Group AG | 320,172 | 23M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 316,453 | 22.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 285,000 | 20.5M $ | as of Mar 31, 2026 |
| 22NW, LP | 281,115 | 20.2M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 279,150 | 20.1M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 275,000 | 19.8M $ | as of Mar 31, 2026 |
| GILDER GAGNON HOWE & CO LLC | 271,758 | 19.6M $ | as of Mar 31, 2026 |
| Nearwater Capital Markets, Ltd | 261,500 | 18.8M $ | as of Mar 31, 2026 |
Declared shareholders of Nektar Therapeutics
3 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 15.00 % | 4,303,188 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.80 % | 2,852,698 | as of Mar 31, 2026 · SCHEDULE 13G |
| Two Seas Capital LP and 2 others | 6.80 % | 1,959,178 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Nektar Therapeutics". https://titelia.com/en/stocks/nektar-therapeutics-US6402683063